Stress is a major risk factor for substance abuse. Intermittent social defeat stress increases drug self-administration (SA) and elevates brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area (VTA) in rats. Intra-VTA BDNF overexpression enhances social defeat stress-induced cross-sensitization to psychostimulants and induces nucleus accumbens (NAc) ΔFosB expression. Therefore, increased VTA BDNF may mimic or augment the development of drug abuse-related behavior following social stress. To test this hypothesis, adeno-associated virus (AAV) was infused into the VTA to overexpress either GFP alone (control) or GFP + BDNF. Rats were then either handled or exposed to intermittent social defeat stress before beginning cocaine SA training. The SA acquisition and maintenance phases were followed by testing on a progressive ratio (PR) schedule of cocaine reinforcement, and then during a 12-h access "binge" cocaine SA session. BDNF and ΔFosB were quantified postmortem in regions of the mesocorticolimbic circuitry using immunohistochemistry. Social defeat stress increased cocaine intake on a PR schedule, regardless of virus treatment. While stress alone increased intake during the 12-h binge session, socially-defeated rats that received VTA BDNF overexpression exhibited even greater cocaine intake compared to the GFP-stressed group. However, VTA BDNF overexpression alone did not alter binge intake. BDNF expression in the VTA was also positively correlated with total cocaine intake during binge session. VTA BDNF overexpression increased ΔFosB expression in the NAc, but not in the dorsal striatum. Here we demonstrate that VTA BDNF overexpression increases long-access cocaine intake, but only under stressful conditions. Therefore, enhanced VTA-BDNF expression may be a facilitator for stress-induced increases in drug abuse-related behavior specifically under conditions that capture compulsive-like drug intake.

La modification de l'activité neuronale peut engendrer des altérations dans des circuits neuronaux. L'activation des récepteurs couplés aux protéines G (RCPG) peux participer à des mécanismes à la base du développement de maladies comme l'addiction à la cocaïne. La consommation de cocaïne conduit à une augmentation de neurotransmetteurs tels que la dopamine, l'histamine et le glutamate qui activent des RCPG dans le cerveau. La signalisation des RCPG peut se faire au travers de monomères, d'homo- ou d'hétéromères de RCPG ainsi que par des interactions protéine - protéine, permettant entre autre une régulation croisée. Nous montrons que les récepteurs de la dopamine 1 (D1R) et de l'histamine 3 (H3R) induisent une signalisation croisée dans le striatum de rat vraisemblablement par la formation d'hétérodimères. Une administration chronique de cocaïne modifie la signalisation de ces récepteurs tant que la signalisation croisée des D1R et H3R. Les H3R et les récepteurs métabotropes du glutamate 1/5 (mGlu1/5R) sont fortement exprimés dans l'hippocampe et le striatum. Des expériences de comportement suggèrent que ces récepteurs seraient susceptibles de coordonner leurs signalisations par une régulation croisée. Nos expériences d'électrophysiologie, de mesure de Ca++ intracellulaire et de transduction du signal montrent effectivement une régulation croisée des récepteurs H3R et mGlu1/5R dans le cerveau de rat. De plus, nous montrons que la consommation chronique de cocaïne affecte la signalisation des H3R et mGlu1/5R de manière différente de son impacte sur leur signalisation croisée. Nos résultats démontrent l'existence d'une régulation croisée de certains RCPG dans le cerveau de rat. De plus, la consommation chronique de la cocaïne affecte différemment la signalisation induite par l'activation d'un récepteur et l'induction d'une signalisation croisée. / Alterations of neuronal activity, mediated by G-protein coupled receptors (GPCRs), can modulate neuronal circuits and are thought to be important in the development and expression of diseases as cocaine addiction. GPCR activity is regulated by various mechanisms, including protein-protein interactions in the membrane, permitting these receptors to crosstalk and form homo-and heteromers. Cocaine blocks monoamine reuptake leading to increased synaptic presence of various neurotransmitters including dopamine, histamine and glutamate in the brain. First we describe that dopamine D1 receptors (D1R) and histamine H3 receptors (H3R) crosstalk in the rodent brain. Chronic cocaine self-administration altered the crosstalk between D1R and H3R in the striatum, a brain structure involved in habit learning and motor control. The altered signaling was observed in both individual receptor signaling and by D1R-H3R crosstalk signaling. Both histamine H¬3R and metabotropic glutamate 1/5 receptors (mGlu1/5R) are highly expressed in the hippocampus and the striatum of rodents and they are involved in behaviors regulated by these structures. We describe that H3R and mGlu1/5R crosstalk in pyramidal neurons of the hippocampus and in the striatum of rats. In addition, we found that signaling through H3R and mGlu1/5R were differently affected by chronic cocaine self-administration than the apparent crosstalk between the receptors. These results show evidence of GPCR interactions in adult rodent brain and reveal that chronic cocaine self-administration differently affected crosstalk and single receptor mediated signaling.

Cocaine is a plant-based illicit drug commonly involved in substance use disorder. Although cocaine overdose and cocaine use disorders cause adverse health consequences to individuals and the economic burden on their family and society, there are no FDA (Food and Drug Administration) approved medications for treatment. Recently, it has been recognized that delivery of cocaine hydrolase (CocH) is a promising therapeutic strategy. Human butyrylcholinesterase (hBChE), the primary enzyme involved in cocaine metabolism in human, have advantages over other candidates for the development of CocH. Previous studies in our laboratory have designed and characterized hBChE mutants that have ~4,000-fold improved catalytic efficiency against naturally occurring (-)-cocaine as compared to the wild-type hBChE. Besides the catalytic efficiency, the biological half-life is another essential factor that influences the desired therapeutic value in the long-term treatment of cocaine use disorder. In order to provide prolonged effects to reduce administration frequency in clinical use, efforts have been made to increase the retention time of CocHs in blood circulation by fusing CocHs with other thermostable proteins or their mutants, including human serum albumin (Albu) or the Fc region of the human IgG (Fc). In this dissertation, we demonstrated the clinical potential and the benefits of long-lasting CocHs for cocaine overdose treatment. We used rodent models to show the ability of AlbuCocH1 to block or reverse manifestations of toxic effects of cocaine. In addition, a concomitant LC-MS/MS-based analysis was conducted to investigate the pharmacokinetic profile of a lethal dose of cocaine with the presence of AlbuCocH1. These experimental data demonstrated AlbuCocH1 as an effective cocaine detoxification agent by accelerating the metabolism of cocaine. In order to examine the potential therapeutic value of Fc-fused CocHs in the treatment of cocaine use disorder, we conducted a series of behavioral experiments in rats to evaluate the effectiveness and duration of Fc-fused CocHs in blocking or attenuating cocaine-induced psychostimulant and discriminative stimulus effects. In addition, the intravenous self-administration model was used to investigate the long-term effectiveness of Fc-fused CocHs in blocking or attenuating the reinforcing effects of cocaine. It has been shown that a single dose of E30-6-Fc (3 mg/kg) was able to effectively alter the cocaine dose-response curve and attenuate the reinforcing efficacy of cocaine for at least a month in both male and female rats. In summary, AlbuCocH1 (TV-1380), which failed to meet the primary efficacy endpoint in clinical trials for facilitating abstinence in cocaine-dependent subjects with a weekly dosing schedule (due to the short biological half-life), is more suitable to be developed as a cocaine detoxification agent. On the contrary, the newly designed Fc-fused CocH (e.g. CocH3-Fc, E30-6-Fc) with higher catalytic efficiency and longer biological half-life will be beneficial for long-term abstinence management in cocaine-dependent individuals.

La plasticité cérébrale pathologique qui se met en place en réponse à l'administration répétée de drogue nécessite des modifications de l’expression des gènes, au moyen,entre autres, de mécanismes épigénétiques tels que la méthylation de l’ADN. Dans ces travaux, nous avons montré que l’inhibition des ADN méthyl transférases par la 5-aza-2’-désoxycytidine augmentait les propriétés renforçantes de la cocaïne dans un protocole d’auto-administration intraveineuse, et ce, sans affecter la motivation des rats pour la cocaïne, ni la réactivation du comportement de recherche après une période de sevrage.L’analyse du méthylome dans le cortex préfrontal médian nous a permis de caractériser près de 190000 régions génomiques différentiellement méthylées suite au traitement par la cocaïne, en association ou non avec la 5-aza-2’-désoxycytidine. Nous avons sélectionné une vingtaine de régions situées soit dans les promoteurs soit au sein de gènes participant à la plasticité neuronale. L’analyse de la transcription de ces gènes a permis, pour certains d’entre eux, de corréler les variations de méthylation avec celles d’expression, comme dans le cas du gène Hdac2. / Repeated drug administration lead to pathological brain plasticity that requires modifications of gene expression through, among others, epigenetic mechanisms such DNA methylation. Here, we showed that DNA methyltransferases inhibitors such 5-aza-2’-deoxycytidine increase reinforcing properties of cocaine in an intravenous self administration paradigm without affecting the motivation of rats for the drug, nor drug seeking after withdrawal. The analysis of the methylome in the medial prefrontal cortex allowed us to identify approximatively 190000 differentially methylated genomic regions in response to cocaine treatment, in association or not with 5-aza-2’-deoxycytidine. We selected around twenty regions within promoters or body of genes known to participate in neuronal plasticity. The study of the transcription of these genes permitted for some of them to correlate the modifications of the DNA methylation with the modifications of the expression, like, for example, in the case of the gene Hdac2.